Teva Pharmaceuticals Sued by U.S. Over Medicare Kickback Claims - BNN Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva Pharmaceuticals - Wikiwand
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
1,498 Teva Photos and Premium High Res Pictures - Getty Images
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Bloomberg New Economy Newsletter: Vaccine Inequality Makes Everyone Lose - Bloomberg
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - KTVZ
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Israel's Teva Buys Allergan's Generics Business For $40 Billion | Fortune
Opioid Suppliers Rebut Claims in Jury Trial Over Epidemic - Bloomberg
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva, Mylan Eye Pfizer's Brazil Venture: Report | Mint
Teva CEO Kare Schultz Says Drugmaker Will Fight US Price-Fixing Charges - Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Watch How to Trade Teva Pharmaceutical - Bloomberg
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva considering cutting up to 10,000 jobs: Bloomberg
Berkshire's 4th Quarter Buy Teva Appears Cheap And Troubled
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Soriot not moving to Teva - Bloomberg - Globes
Aurobindo Pharma Said To Enter Fray For $1.5 Billion Teva Portfolio | Mint
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
